DekaBank Deutsche Girozentrale’s Amphastar Pharmaceuticals AMPH Stock Holding History

DekaBank Deutsche Girozentrale’s Portfolio AMPH Stock Details AMPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-20,848	Closed	-$951K	–	1115
2025 Q4	$951K	Hold	20,848	–	–	﹤0.01%	893
2025 Q3	$550K	Hold	20,848	–	–	﹤0.01%	968
2025 Q2	$475K	Hold	20,848	–	–	﹤0.01%	990
2025 Q1	$580K	Hold	20,848	–	–	﹤0.01%	945
2024 Q4	$772K	Hold	20,848	–	–	﹤0.01%	923
2024 Q3	$989K	Hold	20,848	–	–	﹤0.01%	889
2024 Q2	$832K	Hold	20,848	–	–	﹤0.01%	917
2024 Q1	$892K	Hold	20,848	–	–	﹤0.01%	897
2023 Q4	$1.29M	Hold	20,848	–	–	﹤0.01%	858
2023 Q3	$975K	Buy	20,848 +4,048	+24%	+$221K	﹤0.01%	885
2023 Q2	$944K	Hold	16,800	–	–	﹤0.01%	896
2023 Q1	$624K	Hold	16,800	–	–	﹤0.01%	971
2022 Q4	$470K	Hold	16,800	–	–	﹤0.01%	1051
2022 Q3	$477K	Hold	16,800	–	–	﹤0.01%	1055
2022 Q2	$579K	Hold	16,800	–	–	﹤0.01%	994
2022 Q1	$612K	Buy	16,800 +1,500	+10%	+$42.5K	﹤0.01%	1019
2021 Q4	$351K	Buy	15,300 +400	+3%	+$8.18K	﹤0.01%	1171
2021 Q3	$283K	Hold	14,900	–	–	﹤0.01%	1143
2021 Q2	$299K	Hold	14,900	–	–	﹤0.01%	1143
2021 Q1	$266K	Hold	14,900	–	–	﹤0.01%	1136
2020 Q4	$299K	Hold	14,900	–	–	﹤0.01%	1123
2020 Q3	$274K	Buy	+14,900	New	+$300K	﹤0.01%	1009
2019 Q4	–	Sell	-15,400	Closed	-$311K	–	1145
2019 Q3	$311K	Sell	15,400 -45,400	-75%	-$946K	﹤0.01%	812
2019 Q2	$1.27M	Buy	60,800 +42,100	+225%	+$880K	0.01%	734
2019 Q1	$344K	Buy	18,700 +3,300	+21%	+$73.9K	﹤0.01%	973
2018 Q4	$307K	Sell	15,400 -3,300	-18%	-$65K	﹤0.01%	907
2018 Q3	$344K	Sell	18,700 -500	-3%	-$8.91K	﹤0.01%	995
2018 Q2	$298K	Hold	19,200	–	–	﹤0.01%	995
2018 Q1	$355K	Sell	19,200 -5,400	-22%	-$102K	﹤0.01%	920
2017 Q4	$366K	Hold	24,600	–	–	﹤0.01%	874
2017 Q3	$366K	Hold	24,600	–	–	﹤0.01%	880
2017 Q2	$433K	Hold	24,600	–	–	﹤0.01%	855
2017 Q1	$362K	Sell	24,600 -2,000	-8%	-$31.4K	﹤0.01%	790
2016 Q4	$493K	Buy	26,600 +2,000	+8%	+$38.9K	0.01%	663
2016 Q3	$463K	Hold	24,600	–	–	0.01%	678
2016 Q2	$396K	Buy	24,600 +5,000	+26%	+$70.5K	﹤0.01%	717
2016 Q1	$234K	Sell	19,600 -3,500	-15%	-$41.3K	﹤0.01%	821
2015 Q4	$331K	Buy	23,100 +600	+3%	+$7.92K	﹤0.01%	777
2015 Q3	$263K	Buy	22,500 +800	+4%	+$12K	﹤0.01%	807
2015 Q2	$381K	Buy	21,700 +800	+4%	+$12.5K	﹤0.01%	760
2015 Q1	$313K	Buy	+20,900	New	+$279K	﹤0.01%	818

Other funds holding AMPH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

TD Asset Management Toronto, Ontario, Canada $123B AUM 34.51% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $29.7B AUM 43.33% 1-Year Est. Return

Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

BTW

Boston Trust Walden Boston, Massachusetts $12.2B AUM 12.45% 1-Year Est. Return

DekaBank Deutsche Girozentrale's AMPH Position: Q1 2026 in Review

DekaBank Deutsche Girozentrale sold out of Amphastar Pharmaceuticals (AMPH) in Q1 2026, closing a stake of 20,848 shares — an estimated $951K sold.

DekaBank Deutsche Girozentrale first reported a position in AMPH in Q1 2015 and held it in 41 quarters. The position peaked at $1.29M in Q4 2023. 215 funds tracked by Wall St. Rank hold AMPH as of Q1 2026.

DekaBank Deutsche Girozentrale reported no remaining Amphastar Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
DekaBank Deutsche Girozentrale sold 20,848 Amphastar Pharmaceuticals shares in Q1 2026, an estimated $951K.
DekaBank Deutsche Girozentrale first reported a position in Amphastar Pharmaceuticals in Q1 2015 and held it in 41 quarters.
DekaBank Deutsche Girozentrale's Amphastar Pharmaceuticals position peaked at $1.29M in Q4 2023.
215 funds tracked by Wall St. Rank held Amphastar Pharmaceuticals as of Q1 2026.

Based on DekaBank Deutsche Girozentrale's 13F filing for Q1 2026, filed 7 May 2026.